| Range: | 0.435-6.37 | Vol Avg: | 1079910 | Last Div: | 0 | Changes: | 0.08 |
| Beta: | 1.95 | Cap: | 0.04B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Sep 15 2020 | Empoloyees: | 480 | ||
| CUSIP: | 690145107 | CIK: | 0001484612 | ISIN: | US6901451079 | Country: | US |
| CEO: | Ms. Leslie L. Trigg | Website: | https://www.outsetmedical.com | ||||
OM 0.90 Stock Price Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow